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Cancer has been said to be a “genetic disease,” and even before
the initiation of the Human Genome Project (HGP), the field
of cancer genetics was rapidly growing. Specific genetic alter-
ations were associated with a particular kind of cancer (e.g.,
the 9;22 translocation was found to be diagnostic of chronic
myelogenous leukemia), were associated with patient outcome
(e.g., HER2/neu gene overexpression and/or amplification was
associated with a poor prognosis in breast cancer), or predicted
responsiveness to chemo- or radiotherapy (e.g., breast cancers
with positive estrogen-receptor expression were found to re-
spond to adjuvant tamoxifen therapy). Indeed, we learned that,
depending on the clinical circumstances, individual genetic al-
terations can be diagnostic, prognostic, or predictive (or all
three).
The HGP has only accelerated the growth of molecular on-
cology. Large numbers of genetic alterations are being (and
will be) described in cancer as a result of the HGP. However,
it is not easy to learn the best approaches to determine the
diagnostic, prognostic, or predictive value of such alterations.
A comprehensive, informative, and user-friendly text that de-
scribes such approaches is sorely needed. The volume by Bron-
chud et al. fulfills a large part of this need.
The first section of the book describes general ways to select
and use molecular markers of cancer. Although all chapters in
this section are relevant, the most useful is that written by
Daniel F. Hayes. Dr. Hayes carefully describes the promises
and pitfalls of assessing the clinical usefulness of genetic
markers.
The second section of the volume explores key specific reg-
ulatory pathways that have been shown to be altered in cancer
development. The chapters on growth-factor–signaling path-
way alterations, by Kalderon, and on targeting the cyclin-de-
pendent kinase pathway, by Brizuela et al., are especially
useful.
The final section of the book explores future directions of
clinical and basic molecular oncology. Although predictions of
the direction of science are always somewhat speculative, the
authors in this section make salient and potentially useful pre-
dictions—especially concerning the range of new therapeutic
targets and therapeutic agents.
In summary, “Principles of Molecular Oncology” is a useful
text for both new and experienced investigators in cancer ge-
netics. It provides a framework for learning how to evaluate
the diagnostic, prognostic, and predictive value of the myriad
new cancer-genetic alterations that will result from the HGP.
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